Dyslipidemia and Treatments

Science News

2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke
Omega 3 Fatty Acids for the Management of Hypertriglyceridemia
Establishment of Specialized Clinical Cardiovascular Genetics Programs Recognizing Standards
Cardio Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors
2019 CVD Primary Prevention Guideline

Continuing Education

Registration Now Open

Mark your calendars now to experience the premier global event focusing on improving health by championing scientific discovery and practice-changing educational content.

We can't wait to see you this November! Even though #AHA21 was fully virtual, our flagship meeting brought us together across the globe. If you missed some of our great programming, now is your chance!

Members can now access informative, practice-changing sessions or earn CE credits for free through a different link. And nonmembers can still purchase our Sessions package or our special CE bundle.

The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


The Council on Lifestyle and Cardiometabolic Health promotes the expansion and exchange of knowledge with the ultimate goal of improving cardiovascular health across the lifespan. The council nurtures basic, clinical, epidemiological, and translational science related to nutrition, lipids, obesity, diabetes, physical activity, and behavioral change.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


SOLOIST WHF and SCORED Results

Investigator Deepak Bhatt, MD summarizes the results of 2 trials on dual SGT1 and SGT2 inhibition, which he presented during Scientific Sessions 2020.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses